Company profile
Betagenon AB company profile
Betagenon is a biotechnology company focused on the development of AMP-activated protein kinase (AMPK) activator compounds to treat chronic energy balance disorders diseases in metabolically challenged elderly and/or obese individuals. Drugs that activate AMPK are expected to have beneficial effects on metabolic and cardiovascular diseases and on certain cancers. Their lead AMPK activator compound O304 is currently in Phase IIa clinical trial.
Business identity
- Website
- http://betagenon.se/
- Contact email
- [email protected]
- Phone number
- +46 90154822
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2001-01-01, Year
Headquarters
- Headquarters
- Umeå, Västerbotten, Sweden
- Postal code
- 907 36
- Country code
- SE
- Continent
- Europe